GEODE CAPITAL MANAGEMENT, LLC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 28 filers reported holding UNUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$230,000
+597.0%
98,621
+34.3%
0.00%
Q2 2020$33,000
+10.0%
73,4540.0%0.00%
Q1 2020$30,000
-71.2%
73,454
-50.0%
0.00%
Q4 2019$104,000
-1.0%
146,908
+100.0%
0.00%
Q3 2019$105,000
-45.6%
73,454
-0.6%
0.00%
Q2 2019$193,000
-68.9%
73,882
-47.8%
0.00%
Q1 2019$621,000
-46.7%
141,653
-46.6%
0.00%
Q4 2018$1,166,000
+58.4%
265,130
+270.8%
0.00%
Q3 2018$736,000
-4.5%
71,504
+33.0%
0.00%
Q2 2018$771,00053,7580.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$37,347,00028.23%
Novo Holdings A/S 665,181$31,669,0003.97%
New Leaf Venture Partners, L.L.C. 550,000$6,111,0003.30%
SECTORAL ASSET MANAGEMENT INC 1,081,545$12,016,0001.32%
SABBY MANAGEMENT, LLC 1,106,445$12,292,0000.73%
Monashee Investment Management LLC 175,000$1,944,0000.54%
DC Investments Management, LLC 35,524$395,0000.26%
Athanor Capital, LP 22,300$248,0000.12%
PLATINUM INVESTMENT MANAGEMENT LTD 225,000$2,499,0000.07%
Schonfeld Strategic Advisors LLC 73,000$811,0000.06%
View complete list of UNUM THERAPEUTICS INC shareholders